Live Breaking News & Updates on Biocon biologic

Stay informed with the latest breaking news from Biocon biologic on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Biocon biologic and stay connected to the pulse of your community

Kotak Fund: Kotak Fund to part finance matrix lab founder's Viatris buy

The fund plans to provide a $150 million mezzanine debt facility at 18-20% and arrange another $300 million from other lenders to finance the acquisition, said a person in the know. "The funding cost could vary by the instrument where the blend-in cost could be 14-15%," he added.

Vizag , Andhra-pradesh , India , Hyderabad , Mumbai , Maharashtra , Brijesh-aggarwal , Nimmagadda-prasad , Biocon , Kotak-special-situation-fund , Kotak-group , Kotak-strategic-situations-fund

Biocon Biologics Partners with Sandoz Australia for Biosimilars Trastuzumab and Bevacizumab

Biocon Biologics Ltd (BBL), a fully integrated biosimilars company and subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), today announced a five-year partnership with Sandoz AG ('Sandoz') which provides Sandoz the exclusive rights to promote, sell and distribute biosimilar Trastuzumab (market value of AUD$35 million1) and biosimilar Bevacizumab (market value of AUD$45 million2) in Australia.

Australia , Canada , Japan , India , Australian , Biosimilar-bevacizumab , Matt-erick , Biocon-biologics , Biocon-ltd , Biosimilars-newco , Twitter , Un-sustainable-development-goals-sdgs

Biocon Biologics Ltd.: Biocon Biologics Partners with Sandoz Australia for Biosimilars Trastuzumab and Bevacizumab

Biocon Biologics Ltd.: Biocon Biologics Partners with Sandoz Australia for Biosimilars Trastuzumab and Bevacizumab
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Australia , Canada , Japan , India , Bengaluru , Karnataka , Australian , Biosimilar-bevacizumab , Stefan-klotter , Biocon-biologics , Matt-erick , Biocon-ltd

Biocon Biologics Partners With Sandoz Australia For Biosimilars Trastuzumab And Bevacizuma

Biocon Biologics Partners With Sandoz Australia For Biosimilars Trastuzumab And Bevacizuma
freepressjournal.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from freepressjournal.in Daily Mail and Mail on Sunday newspapers.

Japan , Australia , Matt-erick , Biocon-biologics-ltd , Biocon-ltd-on , Biocon-ltd , Biocon-biologic , Chief-commercial-officer , Advanced-markets ,

Biocon subsidiary partners with Sandoz Australia - The Hindu BusinessLine

Biocon subsidiary partners with Sandoz Australia - The Hindu BusinessLine
thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.

Australia , Japan , Matt-erick , Facebook , Linkedin , Biocon , Biocon-biologics-ltd , Biocon-ltd , Twitter , Biocon-biologic , Chief-commercial-officer , Advanced-markets

biocon q3 earnings: Biocon Q3 Results: PAT at Rs 660 crore vs Rs 42-crore loss a year ago

The company said the revenue growth was supported by income from the divesture of two non-core business assets of Biocon Biologics' branded formulations India business amounting to Rs 350 crore and a gain of Rs 456 crore from Biocons stake dilution in Bicara Therapeutics.

India , Biocon-biologics , Kiran-mazumdar-shaw , Viatris-biosimilars , Mazumdar-shaw , Biocon , Biocon-biologic , Emerging-markets , Biocon-q3-earnings , Biocon-q3 , Biocon-q3-update , Biocon-q3fy24-earnings

That Price Is WAC Boehringer's Push For Access To Humira Biosimilars

That Price Is WAC Boehringer's Push For Access To Humira Biosimilars
lifescienceleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lifescienceleader.com Daily Mail and Mail on Sunday newspapers.

United-states , Coherus-bioscience-yusimry , Samsung-bioepsis , Sandoz-hyrimoz , Fresenius-kabi-idacio , Amgen-amjevita , Abbvie-humira , Samsung-bioepsis-biosmilar , Celltrion-yuflyma , Stephen-pagnotta , Arthritis-foundation , Pfizer

Biocon Biologics, Sandoz sign pact to distribute adalimumab biosimilar Humira in Japan

Adalimumab BS for subcutaneous injection is a biosimilar of Humira, offering therapeutic solutions for immune-related diseases such as rheumatoid arthritis, psoriasis vulgaris, ankylosing spondylitis, Crohn's disease and ulcerative colitis

Japan , Japanese , Biocon-biologics , Biocon-ltd , Fujifilm-kyowa-kirin-biologics-co-ltd , Biocon-biologics-ltd , Biologics-ltd , Adalimumab-biosimilar-market-size , Biocon-biologic , Biocon , Iocon-biologics , Apan

Biocon Biologics concludes integration of acquired biosimilars business in 120 countries

Pharmaceutical giants Biocon Biologics has successfully completed the transition of its acquired biosimilars business in 120 countries across advanced and emerging markets, a year ahead of schedule, an official release stated on Monday. Over 10

Japan , South-africa , India , Philippines , Australia , Brazil , Malaysia , New-zealand , Saudi-arabia , Canada , Thailand , Morocco

Biocon Biologics Concludes Integration of Acquired Biosimilars Business in ~120 countries

Biocon Biologics, a unique, fully integrated, global biosimilars company with a rich portfolio of insulins and monoclonal antibodies, has successfully concluded the integration of the acquired Viatris biosimilars business with the transition of 10+ Emerging Markets and Japan, Australia and New Zealand in the final phase.

Canada , Morocco , Saudi-arabia , India , Brazil , Malaysia , Thailand , South-africa , Philippines , Biocon-biologics , Susheel-umesh , Shreehas-tambe